Diane N. Rafizadeh

Generating author description...

All published works

Action	Title	Year	Authors
+	Application of Traditional Vaccine Development Strategies to SARS-CoV-2	2023	Halie M. Rando Ronan Lordan Alexandra Lee Amruta Naik Nils Wellhausen Elizabeth Sell Likhitha Kolla Anthony Gitter Casey S. Greene V. Bansal
+	The Coming of Age of Nucleic Acid Vaccines during COVID-19	2023	Halie M. Rando Ronan Lordan Likhitha Kolla Elizabeth Sell Alexandra Lee Nils Wellhausen Amruta Naik Jeremy P. Kamil Anthony Gitter Casey S. Greene
+	Identification and Development of Therapeutics for COVID-19	2021	Halie M. Rando Nils Wellhausen Soumita Ghosh Alexandra Lee Anna Ada Dattoli Fengling Hu James Brian Byrd Diane N. Rafizadeh Ronan Lordan Yanjun Qi
+	Identification and Development of Therapeutics for COVID-19.	2021	Halie M. Rando Nils Wellhausen Soumita Ghosh Alexandra Lee Anna Ada Dattoli Fengling Hu James Brian Byrd Diane N. Rafizadeh Ronan Lordan Yanjun Qi

Common Coauthors

Coauthor	Papers Together
Fengling Hu	4
Jeffrey Field	4
Christian Brueffer	4
Bharath Ramsundar	4
Nils Wellhausen	4
Halie M. Rando	4
Alexandra Lee	4
Nafisa M. Jadavji	4
James Brian Byrd	4
Anna Ada Dattoli	4
Yuchen Sun	4
Simina M. Boca	4
Ronan Lordan	4
Rishi R. Goel	4
Marouen Ben Guebila	4
Soumita Ghosh	4
Casey S. Greene	4
YoSon Park	4
Anthony Gitter	4
Ashwin N. Skelly	4
Ariel I. Mundo	2
Amruta Naik	2
Jesse G. Meyer	2
Lamonica Shinholster	2
Lucy D’Agostino McGowan	2
Vincent Rubinetti	2
Elizabeth Sell	2
Ryan Velazquez	2
Jeremy P. Kamil	2
David Manheim	2
Serghei Mangul	2
Temitayo Lukan	2
Yanjun Qi	2
Gregory L. Szeto	2
Michael P. Robson	2
Sandipan Ray	2
Jinhui Wang	2
Joel D. Boerckel	2
John P. Barton	2
John J. Dziak	2
Daniel Himmelstein	2
Adam L. MacLean	2
Yusha Sun	2
Tiago Lubiana	2
Likhitha Kolla	2
Stephen Capone	2
David Mai	2
Dimitri Perrin	2
Yanjun Qi	2
Sergey Knyazev	2

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure	2021	Halie M. Rando Adam L. MacLean Alexandra Lee Ronan Lordan Sandipan Ray V. Bansal Ashwin N. Skelly Elizabeth Sell John J. Dziak Lamonica Shinholster	4
+	Covid-19 has redefined airborne transmission	2021	Julian W. Tang Linsey C. Marr Yuguo Li Stephanie J. Dancer	2
+ PDF Chat	A global database of COVID-19 vaccinations	2021	Edouard Mathieu Hannah Ritchie Esteban Ortiz-Ospina Max Roser Joe Hasell Cameron Appel Charlie Giattino Lucas Rodés-Guirao	2
+ PDF Chat	Systematically Prioritizing Candidates in Genome-Based Drug Repurposing	2019	Anup P. Challa Robert R. Lavieri Judith T. Lewis Nicole M. Zaleski Jana K. Shirey-Rice Paul A. Harris David M. Aronoff Jill M. Pulley	2
+	Identification and Development of Therapeutics for COVID-19	2021	Halie M. Rando Nils Wellhausen Soumita Ghosh Alexandra Lee Anna Ada Dattoli Fengling Hu James Brian Byrd Diane N. Rafizadeh Ronan Lordan Yanjun Qi	2
+ PDF Chat	Three Emerging Coronaviruses in Two Decades	2020	Jeannette Guarner	2
+ PDF Chat	SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat	2020	Jun Zheng	2
+ PDF Chat	A decade after SARS: strategies for controlling emerging coronaviruses	2013	Rachel L. Graham Eric Donaldson Ralph S. Baric	2
+ PDF Chat	Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease	2020	Cintia A. Menéndez Fabian Byléhn Gustavo R. Pérez-Lemus Walter Alvarado Juan Pablo	2
+ PDF Chat	SARS-CoV-2 vaccines in development	2020	Florian Krammer	2
+ PDF Chat	SARS and MERS: recent insights into emerging coronaviruses	2016	Emmie de Wit Neeltje van Doremalen Darryl Falzarano Vincent J. Munster	2
+ PDF Chat	Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing	2020	Sepideh Sadegh Julian Matschinske David B. Blumenthal Gihanna Galindez Tim Kacprowski Markus List Reza Nasirigerdeh Mhaned Oubounyt Andreas Pichlmair Tim Rose	2
+ PDF Chat	Ten scientific reasons in support of airborne transmission of SARS-CoV-2	2021	Trisha Greenhalgh J. L. Jiménez Kimberly A. Prather Zeynep Tüfekçi David N. Fisman Robert T. Schooley	2
+	Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus	2004	Po‐Ren Hsueh Li‐Min Huang Pei‐Jer Chen Chuan‐Liang Kao Pan‐Chyr Yang	2
+	Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile	2021	Alejandro Jara Eduardo A. Undurraga M. Cecilia Gonzalez Corcia Fabio Paredes Tomás Fontecilla Gonzalo Jara Alejandra Pizarro Johanna Acevedo Katherinne Leo Francisco Cázares de León	1
+	India’s DNA COVID vaccine is a world first – more are coming	2021	Smriti Mallapaty	1
+	The effectiveness of SARS-CoV-2 vaccination in preventing severe illness and death – real-world data from a cohort of patients hospitalized with COVID-19	2021	Hari Krishna Raju Sagiraju Arunmozhimaran Elavarasi Nishkarsh Gupta Rishi Garg Saurav Sekhar Paul Saurabh Vig Prashant Sirohiya Brajesh Kumar Ratre Rakesh Garg Anuja Pandit	1
+	Solidarity across borders: A pragmatic need for global COVID‐19 vaccine equity	2021	Denise N. Obinna	1
+ PDF Chat	SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques	2021	Ramon Roozendaal Laura Solforosi Daniel J. Stieh Jan Serroyen Roel Straetemans Anna Dari Muriel Boulton Frank Wegmann Sietske K. Rosendahl Huber Joan E. M. van der Lubbe	1
+	Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa	2021	Juliet R. C. Pulliam Cari van Schalkwyk Nevashan Govender Anne von Gottberg Cheryl Cohen Michelle J. Groome Jonathan Dushoff Koleka Mlisana Harry Moultrie	1
+ PDF Chat	Covid-19: Whatever happened to the Novavax vaccine?	2021	Serena Tinari C Ruga Riva	1
+ PDF Chat	Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic	2021	Harapan Harapan Samsul Anwar Amanda Yufika Khan Sharun Mahir Gachabayov Marhami Fahriani Milda Husnah Rawan Raad Rashed YA. Abdalla Rashed Y. Adam	1
+	Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India	2022	Priyamadhaba Behera Arvind Kumar Singh Sonu Hangma Subba M. C. Arjun Dinesh Prasad Sahu Pradnya Dilip Chandanshive Somen Kumar Pradhan Swayam Pragyan Parida Abhisek Mishra Binod Kumar Patro	1
+	Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa	2022	Juliet R. C. Pulliam Cari van Schalkwyk Nevashan Govender Anne von Gottberg Cheryl Cohen Michelle J. Groome Jonathan Dushoff Koleka Mlisana Harry Moultrie	1
+ PDF Chat	Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study	2022	Alejandro Jara Eduardo A. Undurraga José R. Zubizarreta M. Cecilia Gonzalez Corcia Alejandra Pizarro Johanna Acevedo Katherinne Leo Fabio Paredes Tomás Bralic Verónica Vergara	1
+	COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity	2022	Janina Steinert Henrike Sternberg Hannah Prince Barbara Fasolo Matteo M. Galizzi Tim Büthe Giuseppe Veltri	1
+	CoronaVac efficacy data from Turkey	2021	Martina McMenamin Benjamin J. Cowling	1
+ PDF Chat	Does the World Still Need New Covid-19 Vaccines?	2022	Hanna Nohynek Annelies Wilder‐Smith	1
+ PDF Chat	Key predictors of COVID-19 vaccine hesitancy in Malaysia: An integrated framework	2022	Jason Wei Jian Ng Santha Vaithilingam Mahendhiran Nair Li-Ann Hwang Kamarul Imran Musa	1
+	Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study	2022	Rafaella Fortini Queiroz Grenfell Oyetunde T. Oyeyemi	1
+ PDF Chat	Affordable SARS-CoV-2 protein vaccines for the pandemic endgame	2022	James A. Triccas Joeri Kint Florian Μ. Wurm	1
+	Application of Traditional Vaccine Development Strategies to SARS-CoV-2	2023	Halie M. Rando Ronan Lordan Alexandra Lee Amruta Naik Nils Wellhausen Elizabeth Sell Likhitha Kolla Anthony Gitter Casey S. Greene V. Bansal	1
+	The Coming of Age of Nucleic Acid Vaccines during COVID-19	2023	Halie M. Rando Ronan Lordan Likhitha Kolla Elizabeth Sell Alexandra Lee Nils Wellhausen Amruta Naik Jeremy P. Kamil Anthony Gitter Casey S. Greene	1
+ PDF Chat	Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters	2022	Sapna Sharma Thomas Vercruysse Lorena Sanchez‐Felipe Winnie Kerstens Madina Rasulova Lindsey Bervoets Carolien De Keyzer Rana Abdelnabi Caroline S. Foo Viktor Lemmens	1
+	Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus	2017	Joel N. Maslow	1
+	Randomized controlled trials and real-world data: differences and similarities to untangle literature data	2018	Sara Monti V. Grosso Monica Todoerti Roberto Caporali	1
+	Vaccines based on virus-like nano-particles for use against Middle East Respiratory Syndrome (MERS) coronavirus	2020	Alireza Hashemzadeh Amir Avan Gordon A. Ferns Majid Khazaei	1
+	India’s cost-effective COVID-19 vaccine development initiatives	2020	Chiranjib Chakraborty Govindasamy Agoramoorthy	1
+ PDF Chat	Strategic spatiotemporal vaccine distribution increases the survival rate in an infectious disease like Covid-19	2020	Jens Grauer Hartmut Löwen Benno Liebchen	1
+	Willingness of Long‐Term Care Staff to Receive a <scp>COVID</scp>‐19 Vaccine: A Single State Survey	2020	Kathleen T. Unroe Russell Evans Lindsay Weaver Daniel E. Rusyniak Justin Blackburn	1
+ PDF Chat	Optimal SARS-CoV-2 vaccine allocation using real-time seroprevalence estimates in Rhode Island and Massachusetts	2021	Thu Nguyen-Anh Tran Nathan B. Wikle Joseph Albert Haider Inam Emily R. Strong Karel Břinda Scott M. Leighow Fuhan Yang Sajid Hossain Justin R. Pritchard	1
+	How should we conduct pandemic vaccination?	2021	Jane Williams Chris Degeling Jodie McVernon Angela Dawson	1
+ PDF Chat	Model-informed COVID-19 vaccine prioritization strategies by age and serostatus	2021	Kate M. Bubar Kyle Reinholt Stephen M. Kissler Marc Lipsitch Sarah Cobey Yonatan H. Grad Daniel B. Larremore	1
+ PDF Chat	Vaccine optimization for COVID-19: Who to vaccinate first?	2021	Laura Matrajt Julia Eaton Tiffany Leung Elizabeth R. Brown	1
+	SARS-CoV-2 binding and neutralizing antibody levels after vaccination with Ad26.COV2.S predict durable protection in rhesus macaques	2021	Ramon Roozendaal Laura Solforosi Daniel J. Stieh Jan Serroyen Roel Straetemans Frank Wegmann Sietske K. Rosendahl Huber Joan E. M. van der Lubbe Jenny Hendriks Mathieu Le Gars	1
+	Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization	2021	Guolin Wang Zhuang-Ye Wang Li‐Jun Duan Qing-Chuan Meng Ming-Dong Jiang Jing Cao Lin Yao Ka-Li Zhu Wu‐Chun Cao Mai‐Juan Ma	1
+ PDF Chat	Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts	2021	Thu Nguyen-Anh Tran Nathan B. Wikle Emmy Albert Haider Inam Emily R. Strong Karel Břinda Scott M. Leighow Fuhan Yang Sajid Hossain Justin R. Pritchard	1